Sequent Scientific
PE is negative at -42
THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED
Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane
Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years
Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition
mutual funds have increased stake from 0.25% to 1%
DII also increasing stake significantly
stock has come out of accumulation Phase!!!
THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED
Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane
Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years
Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition
mutual funds have increased stake from 0.25% to 1%
DII also increasing stake significantly
stock has come out of accumulation Phase!!!
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.